Findings suggest that certain medications for type 2 diabetes reduce risk of dementia

A large McGill University study has found that two classes of medications commonly prescribed for type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup